Fig. 7From: Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancerSurvival analysis, indicated by the OS, PPS, DMFS, and RFS, based on DDIT4 expression in patients with TNBC and BC obtained from KM plotterBack to article page